| Thaddeus Ulzen, MD | |
|
850 5th Ave E, Tuscaloosa, AL 35401-7419 | |
| (205) 348-1770 | |
| Not Available |
| Full Name | Thaddeus Ulzen |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 46 Years |
| Location | 850 5th Ave E, Tuscaloosa, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275579146 | NPI | - | NPPES |
| 9993145 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 27386 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capstone Health Services Foundation Pc | 6103724489 | 120 |
News Archive
Cancer Research UK and its commercial arm, Cancer Research Technology have developed a unique test to discover molecules that could lead to potential new treatments for oestrogen receptor (ER)-positive breast cancer.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
University of California, Berkeley, researchers have made a major improvement in CRISPR-Cas9 technology that achieves an unprecedented success rate of 60 percent when replacing a short stretch of DNA with another.
GE Healthcare, a unit of General Electric Company, today announced that DaTSCAN (ioflupane I 123 injection), a radiopharmaceutical agent intended for use with single photon emission computed tomography (SPECT) imaging of the brain, has been recommended in updated European Federation of the Neurological Societies (EFNS) guidelines for the diagnosis and management of Alzheimer's disease (AD). The guidelines appear in the October issue of the European Journal of Neurology.
International Stem Cell Corporation, announces that it has launched fifteen new human cell culture products into the commercial research markets over the last twelve months through its wholly-owned subsidiary, Lifeline Cell Technology, (Walkersville, MD), leading to a 12-month average month-to-month revenue growth of 50%. ISCO, the parent company, is the first company to create human "parthenogenetic" stem cells from unfertilized eggs.
› Verified 4 days ago
| Entity Name | Capstone Health Services Foundation Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740397751 PECOS PAC ID: 6103724489 Enrollment ID: O20040330001160 |
News Archive
Cancer Research UK and its commercial arm, Cancer Research Technology have developed a unique test to discover molecules that could lead to potential new treatments for oestrogen receptor (ER)-positive breast cancer.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
University of California, Berkeley, researchers have made a major improvement in CRISPR-Cas9 technology that achieves an unprecedented success rate of 60 percent when replacing a short stretch of DNA with another.
GE Healthcare, a unit of General Electric Company, today announced that DaTSCAN (ioflupane I 123 injection), a radiopharmaceutical agent intended for use with single photon emission computed tomography (SPECT) imaging of the brain, has been recommended in updated European Federation of the Neurological Societies (EFNS) guidelines for the diagnosis and management of Alzheimer's disease (AD). The guidelines appear in the October issue of the European Journal of Neurology.
International Stem Cell Corporation, announces that it has launched fifteen new human cell culture products into the commercial research markets over the last twelve months through its wholly-owned subsidiary, Lifeline Cell Technology, (Walkersville, MD), leading to a 12-month average month-to-month revenue growth of 50%. ISCO, the parent company, is the first company to create human "parthenogenetic" stem cells from unfertilized eggs.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thaddeus Ulzen, MD P O Box 2153, Dept 5075, Birmingham, AL 35287-0001 Ph: (205) 348-1770 | Thaddeus Ulzen, MD 850 5th Ave E, Tuscaloosa, AL 35401-7419 Ph: (205) 348-1770 |
News Archive
Cancer Research UK and its commercial arm, Cancer Research Technology have developed a unique test to discover molecules that could lead to potential new treatments for oestrogen receptor (ER)-positive breast cancer.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.
University of California, Berkeley, researchers have made a major improvement in CRISPR-Cas9 technology that achieves an unprecedented success rate of 60 percent when replacing a short stretch of DNA with another.
GE Healthcare, a unit of General Electric Company, today announced that DaTSCAN (ioflupane I 123 injection), a radiopharmaceutical agent intended for use with single photon emission computed tomography (SPECT) imaging of the brain, has been recommended in updated European Federation of the Neurological Societies (EFNS) guidelines for the diagnosis and management of Alzheimer's disease (AD). The guidelines appear in the October issue of the European Journal of Neurology.
International Stem Cell Corporation, announces that it has launched fifteen new human cell culture products into the commercial research markets over the last twelve months through its wholly-owned subsidiary, Lifeline Cell Technology, (Walkersville, MD), leading to a 12-month average month-to-month revenue growth of 50%. ISCO, the parent company, is the first company to create human "parthenogenetic" stem cells from unfertilized eggs.
› Verified 4 days ago
Aftab M Khan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2201 Jack Warner Pkwy, Tuscaloosa, AL 35401 Phone: 205-343-9090 Fax: 205-860-6332 | |
Dr. Carlos Eugenio Berry, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3701 Loop Rd, Tuscaloosa Va Medical Center, Tuscaloosa, AL 35404 Phone: 205-554-2822 | |
Dr. Patricia Diane Pilkinton, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3701 Loop Road East, Tuscaloosa Va Medical Center, Tuscaloosa, AL 35404 Phone: 205-554-2822 Fax: 205-554-2894 | |
Aurora Payag Trabajo, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 200 University Blvd, Tuscaloosa, AL 35401 Phone: 205-759-0799 Fax: 205-759-0845 | |
Dr. Jonathan Josef Skonicki, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3701 Loop Rd, Tuscaloosa Va Medical Center,, Tuscaloosa, AL 35404 Phone: 205-554-2000 | |
Madeleine Rachelle Moreno, MSN, PMHNP- BC (CRNP Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 750 Peter Bryce Blvd, Tuscaloosa, AL 35401 Phone: 205-348-6262 | |
Mohammad Aminul Islam, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3701 Loop Road East, Tuscaloosa Va Medical Center, Tuscaloosa, AL 35404 Phone: 205-554-2000 |